UNICHEM LABORATORIES
|
The Current P/E Ratio of UNICHEM LABORATORIES is 290.37.
Share Price | ₹601.0 | May 03,2024 |
Market Cap | ₹4,230.7 Cr | |
Earnings-TTM | ₹14.6 Cr | TTM-Consolidated Results |
Price/Earnings | 290.37x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of UNICHEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,230.7 Cr] as on May 03,2024
(/) Earnings [ ₹14.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 290.37x ]
Thus, for UNICHEM LABORATORIES , the investors are currently willing to pay 290.37 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of UNICHEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of UNICHEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of UNICHEM LABORATORIES
PE Ratio Performance Analysis for UNICHEM LABORATORIES
- UNICHEM LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 23.78x.
- UNICHEM LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, UNICHEM LABORATORIES 's p/e ratio peaked in Mar2021 at 63.44x.
- UNICHEM LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does UNICHEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
UNICHEM LABORATORIES | 14.57 | 290.37 | 4,230.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.22 | 361,916.0 |
CIPLA LTD | 3,744.03 | 30.72 | 115,034.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 20.33 | 105,929.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 33.96 | 100,322.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.83 | 104,873.0 |
MANKIND PHARMA LTD | 1,743.30 | 53.18 | 92,708.2 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.90 | 92,483.6 |
LUPIN LTD | 1,809.74 | 41.68 | 75,438.0 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.31 | 67,541.1 |
ABBOTT INDIA LTD | 1,145.58 | 48.50 | 55,555.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs UNICHEM LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.33x |
Max industry PE | 290.37x |
Median industry PE | 41.68x |
Average industry PE | 65.55x |
You may also like the below Video Courses